{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:02Z","timestamp":1791406982449,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["onlinejcf.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cardfail.2024.08.059","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T19:46:45Z","timestamp":1727293605000},"page":"635-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prescription Patterns in Management of Heart Failure and Its Association With Readmissions: A Retrospective Analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"SIMRAN","family":"AGRAWAL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZAYD","family":"ALHADDAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SARAH","family":"NABIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OBAID UR","family":"REHMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MADIHA","family":"KIYANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJAY","family":"KUMAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NRIPESH","family":"REGMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADHVITHI","family":"PINGILI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TUSHAR","family":"GARG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAKESH","family":"ALLAMANENI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMRIT","family":"PAUDEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GREG C.","family":"FONAROW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANUP","family":"AGARWAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2024.08.059_bib0001","unstructured":"Heart failure. Available from: https:\/\/www.cdc.gov\/heartdisease\/heart_failure.htm.on.12\/12\/2023."},{"key":"10.1016\/j.cardfail.2024.08.059_bib0002","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure \u2013 associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0003","first-page":"E895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0005","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.118.035452","article-title":"Timely management of new-onset heart failure","volume":"140","author":"Gracia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009179","article-title":"Relation of household income to access and adherence to combination sacubitril\/valsartan in heart failure: a retrospective analysis of commercially insured patients","volume":"15","author":"Johnson","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0009","doi-asserted-by":"crossref","DOI":"10.15420\/usc.2020.29","article-title":"Optimizing guideline-directed medical therapies for heart failure with reduced ejection fraction during hospitalization","author":"Dixit","year":"2021","journal-title":"US Cardiol Rev"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0011","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2022.03.009","article-title":"Effects of dapagliflozin according to the Heart Failure Collaboratory medical therapy score: insights from DAPA-HF","volume":"10","author":"Butt","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009729","article-title":"A composite score summarizing use and dosing of evidence-based medical therapies in heart failure: a nationwide cohort study","volume":"16","author":"Johansen","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0013","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2019.11.011","article-title":"Trends in U.S. ambulatory cardiovascular care 2013 to 2017: JACC review topic of the week","volume":"75","author":"Maddox","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0014","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study","volume":"6","author":"Teng","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0015","doi-asserted-by":"crossref","first-page":"e942","DOI":"10.1016\/S2214-109X(18)30360-7","article-title":"Medical therapy for heart failure: the evidence exists, but is it being followed?","volume":"6","author":"Dokainish","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ejhf.2408","article-title":"A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction \u2013 insights from the ESC-HFA EORP Heart Failure Long-Term Registry","volume":"24","author":"Kap\u0142on-Cie\u015blicka","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0017","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0018","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0019","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0020","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","article-title":"Electronic alerts to improve heart failure therapy in outpatient practice: a cluster randomized trial","volume":"79","author":"Ghazi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0021","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamacardio.2023.1266","article-title":"Contemporary use of sodium-glucose cotransporter-2 inhibitor therapy among patients hospitalized for heart failure with reduced ejection fraction in the US: The Get With The Guidelines\u2013Heart Failure Registry","volume":"8","author":"Pierce","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719840192","article-title":"A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans","volume":"13","author":"Tillman","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015042","article-title":"Real-world analysis of guideline-based therapy after hospitalization for heart failure","volume":"9","author":"Wirtz","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0024","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCOUTCOMES.112.965525","article-title":"Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals results from the get with the guidelines-coronary artery disease program","volume":"6","author":"Tam","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2020.08.017","article-title":"Heart failure hospitalization and guideline-directed prescribing patterns among heart failure with reduced ejection fraction patients","volume":"9","author":"Srivastava","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0026","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/ehf2.14051","article-title":"Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes","volume":"9","author":"Palin","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0027","doi-asserted-by":"crossref","unstructured":"Teng T-HK, Tromp J, Ting Tay W, Anand I, Ouwerkerk W, Chopra V, et al. Articles prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. 2018;6:e1008\u201318. Available from: www.thelancet.com\/lancetgh","DOI":"10.1016\/S2214-109X(18)30306-1"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0028","first-page":"154","article-title":"Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction","volume":"9","author":"Wongsalap","year":"2023","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0029","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2018.01.006","article-title":"Effect of optimizing guideline-directed medical therapy before discharge on mortality and heart failure readmission in patients hospitalized with heart failure with reduced ejection fraction","volume":"121","author":"Yamaguchi","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2024.08.059_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2019.07.012","article-title":"The Hospital Readmissions Reduction Program: nationwide perspectives and recommendations","volume":"8","author":"Psotka","year":"2020","journal-title":"JACC Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642400410X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642400410X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:11:27Z","timestamp":1744146687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191642400410X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S107191642400410X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.08.059","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription Patterns in Management of Heart Failure and Its Association With Readmissions: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2024.08.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}